Search for a report

This is a report into how the National Treatment Purchase Fund (NTPF) determined the price paid for procedures purchased, the relevance of Casemix costs to NTPF activity, the proportion of procedures purchased within and without the public health sector and the contribution made by the NTPF to achieving the objective set out in the 2001 Health Strategy to reduce the numbers of persons waiting for treatment for an unacceptable length of time.

This is a report consisting of a Follow-up of 2001 Report Issues Recovery of Overpayments to Doctors and Refunds under the Drugs Payments Scheme.

This is a report on the Extension of Medical Card Eligibility to Persons aged 70 and over and the new Drugs Payment Scheme.

In the audit report, the C&AG indicated that he was undertaking an examination of the provision of the multi-story car park with a view to preparing a special report on the matter. This is the resulting report.

This is a report on the Drugs Initiative to Reduce the Demand for Illegal Drugs by a review of overall management and control of the Initiative and a review effectiveness in the context of projects funded.

The examination focused on the steps being taken to promote more cost effective prescribing within the OMS scheme and to determine whether there is potential for further savings and the extent to which the required improvements identified in the 1994 Strategy document have been implemented.

This is a report on the tribunal costs of the compensation tribunal for those who had contracted Hepatitis C from the use of Human Immunoglobin Anti-D, whole blood or other blood products.